Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
Artrya Limited ( (AU:AYA) ) has shared an announcement.
Artrya Limited has announced the quotation of 2,438,872 new ordinary fully paid securities on the Australian Securities Exchange (ASX), effective from October 3, 2025. This move is part of a previously announced transaction, potentially strengthening the company’s financial position and enhancing its market presence.
The most recent analyst rating on (AU:AYA) stock is a Buy with a A$3.51 price target. To see the full list of analyst forecasts on Artrya Limited stock, see the AU:AYA Stock Forecast page.
More about Artrya Limited
Artrya Limited operates in the medical technology industry, focusing on developing and providing innovative diagnostic solutions for cardiovascular diseases. The company aims to enhance patient outcomes by leveraging advanced imaging and artificial intelligence technologies.
Average Trading Volume: 638,140
Technical Sentiment Signal: Buy
Current Market Cap: A$339.3M
Find detailed analytics on AYA stock on TipRanks’ Stock Analysis page.